218 related articles for article (PubMed ID: 27685149)
1. Classical Hodgkin lymphoma-type PTLD after solid organ transplantation in children: a report on 17 patients treated according to subsequent GPOH-HD treatment schedules.
Kampers J; Orjuela-Grimm M; Schober T; Schulz TF; Stiefel M; Klein C; Körholz D; Mauz-Körholz C; Kreipe H; Beier R; Maecker-Kolhoff B
Leuk Lymphoma; 2017 Mar; 58(3):633-638. PubMed ID: 27685149
[TBL] [Abstract][Full Text] [Related]
2. Treatment and outcomes in classic Hodgkin lymphoma post-transplant lymphoproliferative disorder in children.
Twist CJ; Hiniker SM; Gratzinger D; Gutkin PM; Merriott DJ; Iagaru A; Link MP; Donaldson SS
Pediatr Blood Cancer; 2019 Aug; 66(8):e27803. PubMed ID: 31062898
[TBL] [Abstract][Full Text] [Related]
3. Hodgkin-like posttransplant lymphoproliferative disorder in children: does it differ from posttransplant Hodgkin lymphoma?
Ranganathan S; Webber S; Ahuja S; Jaffe R
Pediatr Dev Pathol; 2004; 7(4):348-60. PubMed ID: 14564542
[TBL] [Abstract][Full Text] [Related]
4. Hodgkin lymphoma-like posttransplant lymphoproliferative disorder (HL-like PTLD) simulates monomorphic B-cell PTLD both clinically and pathologically.
Pitman SD; Huang Q; Zuppan CW; Rowsell EH; Cao JD; Berdeja JG; Weiss LM; Wang J
Am J Surg Pathol; 2006 Apr; 30(4):470-6. PubMed ID: 16625093
[TBL] [Abstract][Full Text] [Related]
5. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
[TBL] [Abstract][Full Text] [Related]
6. Classical Hodgkin lymphoma-like post-transplant lymphoproliferative disease after allogeneic stem cell transplantation for primary myelofibrosis is successfully treated with nivolumab: A case report.
Gunes AK; Demir I; Pehlivan M
J Oncol Pharm Pract; 2021 Mar; 27(2):509-512. PubMed ID: 32762294
[TBL] [Abstract][Full Text] [Related]
7. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
Trappe R; Oertel S; Leblond V; Mollee P; Sender M; Reinke P; Neuhaus R; Lehmkuhl H; Horst HA; Salles G; Morschhauser F; Jaccard A; Lamy T; Leithäuser M; Zimmermann H; Anagnostopoulos I; Raphael M; Riess H; Choquet S; ;
Lancet Oncol; 2012 Feb; 13(2):196-206. PubMed ID: 22173060
[TBL] [Abstract][Full Text] [Related]
8. CD30 expression and survival in posttransplant lymphoproliferative disorders.
Kinch A; Amini RM; Hollander P; Molin D; Sundström C; Enblad G
Acta Oncol; 2020 Jun; 59(6):673-680. PubMed ID: 32102582
[No Abstract] [Full Text] [Related]
9. A case of post-transplant lymphoproliferative disease presenting as CD20-expressing, Epstein-Barr-virus positive Hodgkin lymphoma.
Stern M; Herrmann R; Rochlitz C; Dirnhofer S; Pless M
Eur J Haematol; 2005 Mar; 74(3):267-70. PubMed ID: 15693799
[TBL] [Abstract][Full Text] [Related]
10. CD20 expression predicts survival in paediatric post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation.
Orjuela MA; Alobeid B; Liu X; Siebert AL; Kott ER; Addonizio LJ; Morris E; Garvin JH; Lobritto SJ; Cairo MS
Br J Haematol; 2011 Mar; 152(6):733-42. PubMed ID: 21275950
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of EBV-induced post-transplant Hodgkin lymphoma from Hodgkin-like post-transplant lymphoproliferative disease.
Rohr JC; Wagner HJ; Lauten M; Wacker HH; Jüttner E; Hanke C; Pohl M; Niemeyer CM
Pediatr Transplant; 2008 Jun; 12(4):426-31. PubMed ID: 18466428
[TBL] [Abstract][Full Text] [Related]
12. Pathologic and clinical features of Hodgkin lymphoma--like posttransplant lymphoproliferative disease.
Krishnamurthy S; Hassan A; Frater JL; Paessler ME; Kreisel FH
Int J Surg Pathol; 2010 Aug; 18(4):278-85. PubMed ID: 19578050
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin lymphoma post-transplant lymphoproliferative disorder: A comparative analysis of clinical characteristics, prognosis, and survival.
Rosenberg AS; Klein AK; Ruthazer R; Evens AM
Am J Hematol; 2016 Jun; 91(6):560-5. PubMed ID: 26928381
[TBL] [Abstract][Full Text] [Related]
14. CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.
Maecker B; Jack T; Zimmermann M; Abdul-Khaliq H; Burdelski M; Fuchs A; Hoyer P; Koepf S; Kraemer U; Laube GF; Müller-Wiefel DE; Netz H; Pohl M; Toenshoff B; Wagner HJ; Wallot M; Welte K; Melter M; Offner G; Klein C
J Clin Oncol; 2007 Nov; 25(31):4902-8. PubMed ID: 17971586
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of chemoimmunotherapy (cyclophosphamide, prednisone, and rituximab) in patients with post-transplant lymphoproliferative disorder following solid organ transplantation.
Orjuela M; Gross TG; Cheung YK; Alobeid B; Morris E; Cairo MS
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3945S-52S. PubMed ID: 14506193
[TBL] [Abstract][Full Text] [Related]
16. Low-dose chemotherapy and rituximab for posttransplant lymphoproliferative disease (PTLD): a Children's Oncology Group Report.
Gross TG; Orjuela MA; Perkins SL; Park JR; Lynch JC; Cairo MS; Smith LM; Hayashi RJ
Am J Transplant; 2012 Nov; 12(11):3069-75. PubMed ID: 22883417
[TBL] [Abstract][Full Text] [Related]
17. Post-transplant lymphoproliferative disorders.
Singavi AK; Harrington AM; Fenske TS
Cancer Treat Res; 2015; 165():305-27. PubMed ID: 25655616
[TBL] [Abstract][Full Text] [Related]
18. Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.
Gross TG; Bucuvalas JC; Park JR; Greiner TC; Hinrich SH; Kaufman SS; Langnas AN; McDonald RA; Ryckman FC; Shaw BW; Sudan DL; Lynch JC
J Clin Oncol; 2005 Sep; 23(27):6481-8. PubMed ID: 16170157
[TBL] [Abstract][Full Text] [Related]
19. Posttransplant lymphoproliferative disease after pediatric solid organ transplantation.
Mynarek M; Schober T; Behrends U; Maecker-Kolhoff B
Clin Dev Immunol; 2013; 2013():814973. PubMed ID: 24174972
[TBL] [Abstract][Full Text] [Related]
20. Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy.
Evens AM; Roy R; Sterrenberg D; Moll MZ; Chadburn A; Gordon LI
Curr Oncol Rep; 2010 Nov; 12(6):383-94. PubMed ID: 20963522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]